A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea
Clinical trial NCT04946305 · COMPLETED
Trial details
- NCT number
- NCT04946305
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-10
- Primary completion
- 2024-07-08
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.